Literature DB >> 30948477

PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.

Daniel Fleck1, Lilian Phu2, Erik Verschueren2, Trent Hinkle2, Mike Reichelt3, Tushar Bhangale4, Benjamin Haley5, Yuanyuan Wang1, Robert Graham4, Donald S Kirkpatrick2, Morgan Sheng6, Baris Bingol6.   

Abstract

In addition to amyloid-β plaques and tau tangles, mitochondrial dysfunction is implicated in the pathology of Alzheimer's disease (AD). Neurons heavily rely on mitochondrial function, and deficits in brain energy metabolism are detected early in AD; however, direct human genetic evidence for mitochondrial involvement in AD pathogenesis is limited. We analyzed whole-exome sequencing data of 4549 AD cases and 3332 age-matched controls and discovered that rare protein altering variants in the gene pentatricopeptide repeat-containing protein 1 (PTCD1) show a trend for enrichment in cases compared with controls. We show here that PTCD1 is required for normal mitochondrial rRNA levels, proper assembly of the mitochondrial ribosome and hence for mitochondrial translation and assembly of the electron transport chain. Loss of PTCD1 function impairs oxidative phosphorylation and forces cells to rely on glycolysis for energy production. Cells expressing the AD-linked variant of PTCD1 fail to sustain energy production under increased metabolic stress. In neurons, reduced PTCD1 expression leads to lower ATP levels and impacts spontaneous synaptic activity. Thus, our study uncovers a possible link between a protein required for mitochondrial function and energy metabolism and AD risk.SIGNIFICANCE STATEMENT Mitochondria are the main source of cellular energy and mitochondrial dysfunction is implicated in the pathology of Alzheimer's disease (AD) and other neurodegenerative disorders. Here, we identify a variant in the gene PTCD1 that is enriched in AD patients and demonstrate that PTCD1 is required for ATP generation through oxidative phosphorylation. PTCD1 regulates the level of 16S rRNA, the backbone of the mitoribosome, and is essential for mitochondrial translation and assembly of the electron transport chain. Cells expressing the AD-associated variant fail to maintain adequate ATP production during metabolic stress, and reduced PTCD1 activity disrupts neuronal energy homeostasis and dampens spontaneous transmission. Our work provides a mechanistic link between a protein required for mitochondrial function and genetic AD risk.
Copyright © 2019 the authors.

Entities:  

Keywords:  Alzheimer's disease; PTCD1; energy generation; mitochondria; oxidative phosphorylation

Mesh:

Substances:

Year:  2019        PMID: 30948477      PMCID: PMC6561697          DOI: 10.1523/JNEUROSCI.0116-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  91 in total

1.  Clusterin inhibits apoptosis by interacting with activated Bax.

Authors:  Honglai Zhang; Jin Koo Kim; Chris A Edwards; Zhaohui Xu; Russell Taichman; Cun-Yu Wang
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

2.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.

Authors:  Shengjun Chang; Tian ran Ma; R Dennis Miranda; Maureen E Balestra; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

3.  Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.

Authors:  Taufika Islam Williams; Bert C Lynn; William R Markesbery; Mark A Lovell
Journal:  Neurobiol Aging       Date:  2005-07-01       Impact factor: 4.673

4.  Mitochondrial abnormalities in Alzheimer's disease.

Authors:  K Hirai; G Aliev; A Nunomura; H Fujioka; R L Russell; C S Atwood; A B Johnson; Y Kress; H V Vinters; M Tabaton; S Shimohama; A D Cash; S L Siedlak; P L Harris; P K Jones; R B Petersen; G Perry; M A Smith
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

5.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

6.  Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.

Authors:  Della C David; Susanne Hauptmann; Isabel Scherping; Katrin Schuessel; Uta Keil; Patrizia Rizzu; Rivka Ravid; Stefan Dröse; Ulrich Brandt; Walter E Müller; Anne Eckert; Jürgen Götz
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

7.  Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

Authors:  Casper Caspersen; Ning Wang; Jun Yao; Alexander Sosunov; Xi Chen; Joyce W Lustbader; Hong Wei Xu; David Stern; Guy McKhann; Shi Du Yan
Journal:  FASEB J       Date:  2005-10-06       Impact factor: 5.191

8.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

9.  ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

Authors:  Joyce W Lustbader; Maurizio Cirilli; Chang Lin; Hong Wei Xu; Kazuhiro Takuma; Ning Wang; Casper Caspersen; Xi Chen; Susan Pollak; Michael Chaney; Fabrizio Trinchese; Shumin Liu; Frank Gunn-Moore; Lih-Fen Lue; Douglas G Walker; Periannan Kuppusamy; Zay L Zewier; Ottavio Arancio; David Stern; Shirley ShiDu Yan; Hao Wu
Journal:  Science       Date:  2004-04-16       Impact factor: 47.728

10.  MTG1 codes for a conserved protein required for mitochondrial translation.

Authors:  Antoni Barrientos; Daniel Korr; Karen J Barwell; Christian Sjulsen; Carl D Gajewski; Giovanni Manfredi; Sharon Ackerman; Alexander Tzagoloff
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

View more
  6 in total

1.  Mitochondria and Alzheimer's: Is PTCD1 the Smoking Gun?

Authors:  Judy Pa; Shea J Andrews; Russell H Swerdlow
Journal:  Trends Neurosci       Date:  2019-08-14       Impact factor: 13.837

2.  Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration.

Authors:  Zhongbao Zhou; Yongjian Zhou; Xin Zhou; Yongjin Huang; Yuanshan Cui; Yong Zhang
Journal:  J Oncol       Date:  2022-06-28       Impact factor: 4.501

3.  Developing a Suite of Online Learning Modules on the Components of Next-Generation Sequencing Projects.

Authors:  Robert A Wright
Journal:  Med Ref Serv Q       Date:  2020 Jan-Mar

Review 4.  Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?

Authors:  Simon M Bell; Katy Barnes; Matteo De Marco; Pamela J Shaw; Laura Ferraiuolo; Daniel J Blackburn; Annalena Venneri; Heather Mortiboys
Journal:  Biomedicines       Date:  2021-01-11

Review 5.  Glucose metabolic crosstalk and regulation in brain function and diseases.

Authors:  Shuai Zhang; Brittany Bolduc Lachance; Mark P Mattson; Xiaofeng Jia
Journal:  Prog Neurobiol       Date:  2021-06-10       Impact factor: 10.885

6.  The heterogeneity among subgroups of haplogroup J influencing Alzheimer's disease risk.

Authors:  HaoChen Liu; Yixuan Zhang; Huimin Zhao; Yanan Du; XiaoQuan Liu
Journal:  J Adv Res       Date:  2021-02-17       Impact factor: 10.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.